Media Releases

2021

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline – Market Watch

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline

03/11/2021

Proteomics (ASX:PIQ) awarded $100,000 project grant – The Market Herald

03/11/2021

Proteomics International awarded $100,000 manufacturing funding

18/10/2021

Clinical study boosts Proteomics kidney test – The West Australian

12/08/2021

Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald

12/08/2021

Blood test or crystal ball? Looking into the future of our health – The Sentiment

12/08/2021

Proteomics International contracts Biotem to manufacture PromarkerD test kits

11/08/2021

Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress

10/08/2021

Endometriosis Blood Test – ABC Radio

05/08/2021

Proteomics International to collaborate with University of Melbourne and Royal Women’s Hospital to develop a test for endometriosis – Proactive Investors

04/08/2021

Proteomics International to collaborate on world first blood test for endometriosis – The Sentiment

04/08/2021

Proteomics to collaborate to validate test for endometriosis

23/07/2021

6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel

22/07/2021

Proteomics International engages Abcam to manufacture PromarkerD reagents – Proactive Investors

Subscribe

  • This field is for validation purposes and should be left unchanged.